Open Orphan continues talks over coronavirus challenge study

Open Orphan updated the market on its talks with the UK government and other partners for a coronavirus challenge study in the UK on Friday, confirming that “advanced negotiations” were ongoing.

The AIM-traded firm said no contract had been signed, however.

“The company will update the market in due course as appropriate,” the board said in its short statement.

At 1355 BST, shares in Open Orphan were up 5.68% at 27.74p.